Dr. Reddy's Laboratories LimitedRDYNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank31
Year-over-Year Change
Year-over-year operating cash flow growth rate
Percentile
P31
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -29.96% |
| Q3 2025 | 6.45% |
| Q2 2025 | -33.49% |
| Q1 2025 | 232.27% |
| Q4 2024 | -28.94% |
| Q3 2024 | 9.65% |
| Q2 2024 | 6138.25% |
| Q1 2024 | 156.22% |
| Q4 2023 | -99.70% |
| Q3 2023 | 59.34% |
| Q2 2023 | -42.83% |
| Q1 2023 | -15.40% |
| Q4 2022 | 150.62% |
| Q3 2022 | 39.46% |
| Q2 2022 | -27.02% |
| Q1 2022 | -47.38% |
| Q4 2021 | 239.42% |
| Q3 2021 | 248.09% |
| Q2 2021 | -2347.33% |
| Q1 2021 | 162.47% |
| Q4 2020 | -99.37% |
| Q3 2020 | -15.20% |
| Q2 2020 | 37158.86% |
| Q1 2020 | -99.60% |
| Q4 2019 | -27.21% |
| Q3 2019 | 2.78% |
| Q2 2019 | 46.52% |
| Q1 2019 | -58.80% |
| Q4 2018 | 51.82% |
| Q3 2018 | 313.62% |
| Q2 2018 | -186.87% |
| Q1 2018 | -23.13% |
| Q4 2017 | 12.12% |
| Q3 2017 | 438.91% |
| Q2 2017 | -123.24% |
| Q1 2017 | 62.76% |
| Q4 2016 | 93.17% |
| Q3 2016 | -46.40% |
| Q2 2016 | -45.40% |
| Q1 2016 | -22.86% |